drugset / Trial / NCT00485680

Olanzapine Versus Comparator in the Treatment of Bipolar Disorder

NCT00485680

Phase 3 Completed 140 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this trial is compare the efficacy of olanzapine and Lithium Carbonate in the treatment of bipolar disorder, manic or mixed episodes, in Chinese patients.

Timeline

Start
2003-12
Primary completion
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Lithium Carbonate Unknown
Subject Olanzapine Small molecule

Indications